drugset / Trial / NCT01577381
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the efficacy, safety and tolerability of multiple doses of RN6G in subjects with Geographic Atrophy Secondary to Age-related Macular Degeneration.
Timeline
- Start
- 2012-08
- Primary completion
- 2013-09
- Completion
- 2013-10
Outcome
Outcome not reported
Stopped: “See termination reason in detailed description.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RN6G | Unknown | 2.5 mg/kg | Intravenous |
| Subject | RN6G | Unknown | 15 mg/kg | Intravenous |